IMARC Group, a leading market research company, has recently releases report titled “India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the India generic injectables market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the India generic injectables market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.4 Billion |
| Market Forecast in 2028 | US$ 4.9 Billion |
| Growth rate (2023 to 2028) | CAGR of 12.4% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is India generic injectables?
Generic injectables represent alternative drugs that are bio-equivalent of their branded counterparts in terms of strength, quality, effectiveness, active ingredients, intended use, dosage, etc. In addition to this, as compared to innovator drugs, they offer maximized patient compliance, reduced frequency of drug delivery, limited price erosion, higher profitability for manufacturers, etc. Consequently, generic injectables are extensively utilized to treat several life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, respiratory infections, etc.
Request Free Sample Report: https://www.imarcgroup.com/india-generic-injectables-market/requestsample
What are the growth prospects and trends in the India generic injectables industry?
The expanding geriatric population who are susceptible to developing numerous medical ailments, including septicemia, influenza, pneumonia, etc., is among the key factors stimulating the India generic injectables market. Moreover, the increasing occurrence of chronic disorders, on account of the growing pollution levels and hectic schedules, changing dietary patterns, and the sedentary lifestyles of individuals, is acting as another significant growth-inducing factor. Besides this, the launch of favorable policies undertaken by government bodies in India to support leading manufacturers and sellers is catalyzing the market growth. Furthermore, various technological advancements in drug delivery systems, such as the introduction of self-injection devices, are also propelling the market growth across the country. Apart from this, the rising number of health insurance companies and the expiry of patents of branded drugs are further augmenting the market growth. Additionally, the development of 3D printing technology by key market players that helps in producing these medicines with varying release dates and tastes and continuous improvements in healthcare facilities are anticipated to fuel the India generic injectables market over the forecasted period.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
Breakup by Container:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
Breakup by Region:
- North India
- West and Central India
- South India
- East India
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4026&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
